{"type":"rich","title":"Teplizumab For Diabetes Episode 315 \u2013 Real Life Pharmacology Podcast","version":"1.0","provider_name":"Blubrry","provider_url":"https://blubrry.com","author_name":"Real Life Pharmacology - Pharmacology Education for Health Care Professionals","html":"<iframe src=\"https://player.blubrry.com/?podcast_id=130962628\" title=\"Blubrry Podcast Player\" scrolling=\"no\" width=\"100%\" height=\"230\" frameborder=\"0\"></iframe>","height":"230","description":"Teplizumab is a relatively new agent that helps delay the progression of type 1 diabetes. It slows the rate of beta-cell destruction in the pancreas.     Teplizumab is associated with cytokine release","thumbnail_url":"https://assets.blubrry.com/coverart/160/542381.jpg"}